Theriva Biologics Inc (TOVX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 26,346 | 21,431 | 21,581 | 14,274 | 10,160 |
| Operating Income | -26,346 | -21,431 | -21,581 | -14,274 | -10,160 |
| Other Income | 693 | 1,442 | 471 | 6 | 44 |
| Pre-tax Income | -25,653 | -19,989 | -21,110 | -14,268 | -10,116 |
| Income Tax | N/A | -1,640 | -1,425 | N/A | N/A |
| Net Income Continuous | -25,653 | -18,349 | -19,685 | -14,268 | -10,116 |
| Minority Interests | N/A | N/A | N/A | -1 | -73 |
| Net Income | $-25,653 | $-18,349 | $-19,685 | $-14,267 | $-10,043 |
| EPS Basic Total Ops | -19.03 | -28.48 | -32.75 | -47.50 | -165.00 |
| EPS Basic Continuous Ops | -19.03 | -28.48 | -32.11 | -29.27 | -133.03 |
| EPS Diluted Total Ops | -19.03 | -28.48 | -32.75 | -47.50 | -165.00 |
| EPS Diluted Continuous Ops | -19.03 | -28.48 | -32.11 | -29.27 | -133.03 |
| EPS Diluted Before Non-Recurring Items | -19.03 | -28.50 | -32.75 | -47.50 | -165.00 |
| EBITDA(a) | $-20,615 | $-21,296 | $-21,496 | $-14,187 | $-9,959 |